accountgrowth and shorten survival times. Sales of rheumatoid-arthritis drug Enbrel, sold by Amgen in North America and by Wyeth Inc. (WYE) elsewhere, fell slightly. For 2010, Amgen projected adjusted earnings of $5.05 to $5.25 a share on revenue of $15.1...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Amgen 4Q Profit Up Slightly; Company Submits Key Data To FDA
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account